CASP2 and neuroblastoma: Loss of caspase-2 inconsistently delayed tumorigenesis in a MYCN mouse model of neuroblastoma (TH-MYCN), in which MYCN was constitutively expressed under the control of the rat tyrosine hydroxylase promoter.